Skip to main content
Equibles
CARL logo

CARL · Carlsmed, Inc. · Metrics

Track CARL — free

Use CARL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$15.23 -0.37 (-2.37%) At close · Sep 8
Russell 2000 member Rebalance outlook locked
Market Cap
$415.96M
Shares
27.30M

CARL metrics

67 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$15.23
Market cap
$415.96M

Price action

20 metrics
Price change (1W)
-7.6%
Price change (30D)
+13.6%
Price change (3M)
+40.9%
Price change (6M)
+30.0%
Price change (YTD)
+26.3%
Price change (1Y)
+20.8%
Trailing year
Price change (5Y)
—
52-week high
$16.99
52-week low
$8.83
Change from 52-week high
-8.2%
Change from 52-week low
+76.7%
Annualized volatility
72.8%
Annualized volatility (3M)
65.1%
Beta
1.1
RSI (14D)
57.3
Price vs SMA 50
+16.8%
Price vs SMA 200
+28.5%
Avg volume (3M)
145,484
Relative volume
0.3
Average dollar volume
$1.89M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
27.30M

Valuation

12 metrics
P / E (TTM)
141.8
Trailing earnings · reciprocal yield 0.7%
PEG ratio
—
EV / revenue
5.7×
reciprocal yield 17.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.6×
reciprocal yield 15.2%
P / book
4.9
reciprocal yield 20.3%
FCF yield
-8.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
76.6%
Operating margin
-61.1%
Trailing 12 months
Net margin
-57.4%
Gross profit (TTM)
$48.50M
Operating profit (TTM)
−$38.66M
Net income (TTM)
−$36.34M
Trailing 12 months
Diluted EPS (TTM)
$0.11
FCF margin
-54.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-17.06

Growth

11 metrics
Revenue growth YoY
+56.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$63.30M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+492.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-43.1%
Return on assets
-30.7%
Debt / equity
0.2
Current ratio
8.8
EBITDA (TTM)
−$38.26M
Free cash flow (TTM)
−$34.58M
Quick ratio
8.7
Interest coverage
-29.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$54.86M
Latest balance sheet
Cash & equivalents
$46.24M
Total assets
$118.20M
Total debt
$15.38M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$34.15M
Capital expenditures (TTM)
$432,000
R&D (TTM)
$20.93M
SG&A (TTM)
—
Stock compensation (TTM)
$5.39M
R&D / revenue
33.1%
Stock compensation / revenue
8.5%

Ownership (13F)

3 metrics
13F filers
74
13F filer change QoQ
+8
Institutional ownership
20.9%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1794546 CUSIP 14280C105 13F (30d) 50 filings 50 filers Visit website Investor relations